Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02539927 · ClinicalTrials.gov registry record
Validation Study of the SAGIT® Instrument in Acromegaly
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 227
- Enrollment target
NCT02539927: Completed study, sponsored by Ipsen.
NCT02539927 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 227 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02539927 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
Patients will be treated in accordance with the standard medical practice of the hospital where they have been recruited during their participation in this study. No additional assessments or tests will be required. SAGIT® is a new instrument developed by a group of acromegaly experts to help practicing endocrinologists to manage acromegalic patients and disease activity in their clinical practice and define acromegaly staging. It reports 5 elements: Signs and symptoms - S; Associated comorbidities - A; Growth hormone (GH) concentration - G; Insulin-like growth factor 1(IGF-1) concentration -I; Tumour size- T. The instrument has been pre evaluated during a qualitative pilot study. The purpose of the validation study is to define and validate the scoring of the SAGIT® instrument.
Primary Outcome
Evaluating the ability of the instrument to discriminate subgroups of subjects with acromegaly (controlled vs not controlled).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-09-03 |
What the finished NCT02539927 record still lists
NCT02539927 is an observational study that tracks outcomes without assigning an intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02539927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02539927 about?
NCT02539927 is a clinical study titled "Validation Study of the SAGIT® Instrument in Acromegaly". Patients will be treated in accordance with the standard medical practice of the hospital where they have been recruited during their participation in this study. No additional assessments or tests will be required. SAGIT® is a new instrument developed by a group of acromegaly experts to help pract...
What is the current status of trial NCT02539927?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2015-07. Estimated completion is 2018-09-03.
Who is sponsoring clinical trial NCT02539927?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04751409 · 227 participants · Phase 2
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- NCT05742360 · 227 participants
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
- NCT05890352 · 227 participants · Phase 2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia